Search research articles
Contact Us
Filters
Showing results (1-10 of 18) with videos related to
Page
of 2
Sort By:
Mediterranean Journal of Hematology and Infectious Diseases
|
September 13, 2017
Solitary Plasmacytoma
Sara Grammatico, Emilia Scalzulli, Maria Teresa Petrucci
Blood and Lymphatic Cancer : Targets and Therapy
|
July 31, 2019
Managing treatment-related peripheral neuropathy in patients with multiple myeloma
Sara Grammatico, Laura Cesini, Maria Teresa Petrucci
Expert Opinion on Pharmacotherapy
|
February 27, 2018
Proteasome inhibitors for the treatment of multiple myeloma
Emilia Scalzulli, Sara Grammatico, Federico Vozella, et al.
British Journal of Haematology
|
June 7, 2016
Blastic plasmacytoid dendritic cell neoplasm: diagnostic criteria and therapeutical approaches
Livio Pagano, Caterina G Valentini, Sara Grammatico, et al.
British Journal of Haematology
|
December 20, 2015
Clinical features and prognostic factors in solitary plasmacytoma
Paola Finsinger, Sara Grammatico, Marta Chisini, et al.
Cancer Chemotherapy and Pharmacology
|
January 22, 2009
Sequential development of mutant clones in an imatinib resistant chronic myeloid leukaemia patient following sequential treatment with multiple tyrosine kinase inhibitors: an emerging problem?
Massimo Breccia, Anna Maria Frustaci, Laura Cannella, et al.
BMC Infectious Diseases
|
March 12, 2017
Carbapenem-resistant Klebsiella pneumoniae in high-risk haematological patients: factors favouring spread, risk factors and outcome of carbapenem-resistant Klebsiella pneumoniae bacteremias
Alessandra Micozzi, Giuseppe Gentile, Clara Minotti, et al.
European Journal of Haematology
|
May 3, 2018
Cyclophosphamide's addition in relapsed/refractory multiple myeloma patients with biochemical progression during lenalidomide-dexamethasone treatment
Laura Cesini, Agostina Siniscalchi, Sara Grammatico, et al.
Cancer
|
October 26, 2012
Bortezomib, melphalan, and prednisone in elderly patients with relapsed/refractory multiple myeloma: a multicenter, open label phase 1/2 study
Maria Teresa Petrucci, Anna Levi, Sara Bringhen, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
June 16, 2012
Controlled-release oxycodone for the treatment of bortezomib-induced neuropathic pain in patients with multiple myeloma
Claudio Cartoni, Gregorio Antonio Brunetti, Vincenzo Federico, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 18) with videos related to
Sort By:
Page
of 2
Mediterranean Journal of Hematology and Infectious Diseases
|
September 13, 2017
Solitary Plasmacytoma
Sara Grammatico, Emilia Scalzulli, Maria Teresa Petrucci
Blood and Lymphatic Cancer : Targets and Therapy
|
July 31, 2019
Managing treatment-related peripheral neuropathy in patients with multiple myeloma
Sara Grammatico, Laura Cesini, Maria Teresa Petrucci
Expert Opinion on Pharmacotherapy
|
February 27, 2018
Proteasome inhibitors for the treatment of multiple myeloma
Emilia Scalzulli, Sara Grammatico, Federico Vozella, et al.
British Journal of Haematology
|
June 7, 2016
Blastic plasmacytoid dendritic cell neoplasm: diagnostic criteria and therapeutical approaches
Livio Pagano, Caterina G Valentini, Sara Grammatico, et al.
British Journal of Haematology
|
December 20, 2015
Clinical features and prognostic factors in solitary plasmacytoma
Paola Finsinger, Sara Grammatico, Marta Chisini, et al.
Cancer Chemotherapy and Pharmacology
|
January 22, 2009
Sequential development of mutant clones in an imatinib resistant chronic myeloid leukaemia patient following sequential treatment with multiple tyrosine kinase inhibitors: an emerging problem?
Massimo Breccia, Anna Maria Frustaci, Laura Cannella, et al.
BMC Infectious Diseases
|
March 12, 2017
Carbapenem-resistant Klebsiella pneumoniae in high-risk haematological patients: factors favouring spread, risk factors and outcome of carbapenem-resistant Klebsiella pneumoniae bacteremias
Alessandra Micozzi, Giuseppe Gentile, Clara Minotti, et al.
European Journal of Haematology
|
May 3, 2018
Cyclophosphamide's addition in relapsed/refractory multiple myeloma patients with biochemical progression during lenalidomide-dexamethasone treatment
Laura Cesini, Agostina Siniscalchi, Sara Grammatico, et al.
Cancer
|
October 26, 2012
Bortezomib, melphalan, and prednisone in elderly patients with relapsed/refractory multiple myeloma: a multicenter, open label phase 1/2 study
Maria Teresa Petrucci, Anna Levi, Sara Bringhen, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
June 16, 2012
Controlled-release oxycodone for the treatment of bortezomib-induced neuropathic pain in patients with multiple myeloma
Claudio Cartoni, Gregorio Antonio Brunetti, Vincenzo Federico, et al.
Page
of 2